Home | Welcome to Contract Pharma   
Last Updated Wednesday, August 20 2014
Print

Search Results for 'contractpharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published March 1, 2011
Contract Pharma Editorial Staff Editor Gil Y. Roth Editorial Director Tom Branna Associate Editor Kristin Brooks Editor at Large Tom Spurg… Read More »
Published February 28, 2011
Contract Pharma and ContractPharma.com are leaders in coverage of the Pharma outsourcing industry. ContractPharma.com is quickly becoming one of the most visited sites on the Internet for pharma and biopharma decision-makers looking for th… Read More »
Contract Pharma Team
Published February 28, 2011
Contract Pharma Team President, Rodman J. Zilenziger, Jr. Rodman J. Zilenziger Jr. — President of Rodman Media since 1993. Zilenziger, son of the Company’s founder, joined Rodman Media as an Advertising Representa… Read More »
Biopharma CMO Update
By William Downey , HighTech Business Decisions
Published June 3, 2014
Increased demand is driving higher capacity utilization and more partnerships Read More »
Improving the Functional Characterization of Biosimilars
By Delana Butz, Ph.D., Manuela Grassi, Ph.D, Onesmo Mpanju, Ph.D., Duu-Gong Wu, Ph.D., Peter Wunderli, Ph.D. , PPD
Published June 3, 2014
New bioassay methods may help reduce the variability of analytical methods required to demonstrate comparability Read More »
Newsmakers: Jim Mullen
By James Mullen, Patheon
Published January 22, 2014
Patheon/DSM, industry trends, and more, with the CEO of Patheon Read More »
Top 50 (or so) Biopharma Products
By Ronald A. Rader
Published July 18, 2012
Ranking the top 57 biopharma products by 2011 revenues Read More »
U.S. CMO Market Report
By Jesse Sullivan and Jennifer Brice, Frost & Sullivan
Published May 30, 2012
A growth industry in transition Read More »
Published April 3, 2014
AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a s… Read More »
High Potency Regulations
By Stephanie Wilkins, PharmaConsult US, Inc.
Published November 13, 2013
Uncertainty remains in the quest to define certain products Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On